<Disease><Name>EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6</Name><Synonym>DRAVET SYNDROME</Synonym><OMIM><Number>607208</Number><URL>http://omim.org/entry/607208</URL></OMIM><Orphanet><Number>33069</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=33069</URL></Orphanet><Protein><Number>Sodium channel protein type 1 subunit alpha</Number><URL>http://www.uniprot.org/uniprot/P35498</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>2q24.3</Gene><ICD>G40.4</ICD><Summary>rare;autosomal dominant;mutation in the SCN1A gene (80%)</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1956</id><symptom>behavior, autism or autistic-like / behaviour, autism or autistic-like</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1955</id><symptom>behavior, hyperactive, restless / behaviour, hyperactive, restless</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2261</id><symptom>hyperreflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>3681</id><symptom>seizures, absence / seizures</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>4041</id><symptom>seizures, myoclonic</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3967</id><symptom>status epilepticus</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>502</id><name>no specific laboratory findings (P, S, U ,CSF)</name><specimen /><value /><min>    </min><max>    </max><unit /><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>8195</id><title>The Direct Costs of Dravets Syndrome before and after Diagnosis Assessment</title><author>Ceska K,</author><journal>Neuropediatrics</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>8196</id><title>Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome</title><author>Lattanzi S,</author><journal>Expert Rev Neurother</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>8197</id><title>A novel GABRB3 variant in Dravet syndrome: Case report and literature review</title><author>Pavone P,</author><journal>Mol Genet Genomic Med</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages>e1461</pages><co_aut>et al.</co_aut></literature><literature><id>8198</id><title>Intellectual functioning and behavior in Dravet syndrome: A systematic review</title><author>Jansson JS,</author><journal>Epilepsy Behav</journal><year>2020</year><book /><volume>108</volume><number>0</number><pages>107079</pages><co_aut>Hallb&#246;&#246;k T, Reilly C.</co_aut></literature><literature><id>8200</id><title>Dravet Syndrome: A Review of Current Management</title><author>Wheless JW,</author><journal>Pediatr Neurol</journal><year>2020</year><book /><volume>107</volume><number>0</number><pages>28-40</pages><co_aut>Fulton SP, Mudigoudar BD</co_aut></literature><literature><id>8199</id><title>Autism spectrum disorder and cognitive profile in children with Dravet syndrome: Delineation of a specific phenotype</title><author>Ouss L,</author><journal>Epilepsia Open</journal><year>2018</year><book /><volume>4</volume><number>1</number><pages>40-53</pages><co_aut>et al.</co_aut></literature><literature><id>5620</id><title>Dravet syndrome and its mimics: Beyond SCN1A</title><author>Steel D,</author><journal>Epilepsia</journal><year>2017</year><book /><volume>58</volume><number>11</number><pages>1807-1816</pages><co_aut>et al.</co_aut></literature><literature><id>5626</id><title>From genotype to phenotype in Dravet disease</title><author>Gataullina S,</author><journal>Seizure</journal><year>2017</year><book /><volume>44</volume><number>0</number><pages>58-64</pages><co_aut>Dulac O</co_aut></literature><literature><id>5622</id><title>Mortality in Dravet syndrome: A review</title><author>Shmuely S,</author><journal>Epilepsy Behav</journal><year>2016</year><book /><volume>64</volume><number>0</number><pages>69-74</pages><co_aut>et al.</co_aut></literature><literature><id>5623</id><title>Dravet Syndrome: Diagnosis and Long-Term Course</title><author>Connolly MB</author><journal>Can J Neurol Sci Suppl</journal><year>2016</year><book /><volume>43</volume><number>3</number><pages>S3-S8</pages><co_aut /></literature><literature><id>5624</id><title>Treatment of Dravet Syndrome</title><author>Wirrell EC</author><journal>Can J Neurol Sci Suppl</journal><year>2016</year><book /><volume>43</volume><number>3</number><pages>S13-S18</pages><co_aut /></literature><literature><id>5627</id><title>Dravet syndrome, what is new?</title><author>Al-Baradie RS</author><journal>Neurosciences (Riyadh)</journal><year>2013</year><book /><volume>18</volume><number>1</number><pages>11-17</pages><co_aut /></literature><literature><id>5625</id><title>Diagnosis and long-term course of Dravet syndrome</title><author>Scheffer IE</author><journal>Eur J Paediatr Neurol Suppl</journal><year>2012</year><book /><volume>16</volume><number>1</number><pages>S5-S8</pages><co_aut /></literature><literature><id>5621</id><title>Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome</title><author>Depienne C,</author><journal>J Med Genet</journal><year>2010</year><book /><volume>47</volume><number>6</number><pages>404-410</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>